Diuretics & CHF Drugs Flashcards
adverse effects of carbonic anhydrase inhibitors (4)
Hyperchloremia
Hypokalemia
Hyperuricemia
Diuretic effect decreases
site of carbonic anhydrase activity
proximal convoluted tubule
loop diuretic MOA (2 things)
block the Na+K+2Cl- cotransporter
induce kidney prostaglandins
loop diuretic ion effects (4)
hypokalemic metabolic acidosis
hypochloremia
hyperuricemia
increased Ca and Mg excretion
thiazide MOA and site
inhibits NaCl co-transporter
distal convoluted tubule
thiazide ion effects (5)
hypokalemia metabolic acidosis hyperuricemia hyperglycema increased serum lipids increased Ca reabsorption
Chlorthalidone characteristic
longer duration
indapamide characteristics (3)
causes vasodilation
doesn’t increase lipids
liver metabolism
metolazone characteristic
works in pts w/ reduced GFR
which diuretics are sulfonamides (3)
carbonic anhydrase inhibitors
loops
thiazides
which diuretics aren’t acids (2)
amiloride
triamterene
DOC for htn?
thiazides
amiloride MOA & site
directly inhibit aldosterone-sensitive Na+ channel
collecting duct
spironolactone MOA & site
competitive aldosterone inhibitor —> decreased Na+K+ATPase activity
collecting duct
aldosterone antagonist main adverse effects (2)
gynecomastia
hyperkalemia
drug used for renal failure prophylaxis?
osmotic diuretics
diuretic combos? (2)
loop agents + thiazides
K+ sparing diuretics + loops/thiazides
digitalis MOA
inhibition of the Na+K+ATPase pump –> increases intracellular Ca –> increases actin-myosin interaction
effects of digitalis (4)
increased contractility
decreased HR
reduced sympathetic tone
increased CO in the failing heart
earliest signs of digitalis toxicity
GI symptoms due to increased parasymp. tone
digitalis adverse effects (2)
arrhytmias
Bigeminy
inamrinone and milrinone are?
PDE inhibitors
PDE indication
increase CO in end stage heart failure
PDE adverse effect
arrhythmias
B-blockers effects in CHF (5)
decrease cardiac workload decrease renin secretion attenuate effect of high catecholamine release decrease HR decrease cardiac remodeling
DOC for CHF
ACE inhibitors
ACE-i & ARB MOA (2)
decreased afterload: AngII-induced vasoconstriction
Decreased preload: decreased aldosterone release
vasodilator MOA in CHF
reduce preload: venodilation
reduce afterload: arteriolar dilation
decrease heart remodeling